M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort.
Lawrence Long,Alana T. Brennan,Alana T. Brennan,Matthew P. Fox,Buyiswa Ndibongo,Imogen Jaffray,Ian Sanne,Ian Sanne,Sydney Rosen,Sydney Rosen +9 more
TL;DR: It is reported that “down-referring” stable HIV patients from a doctor-managed, hospital-based ART clinic to a nurse-managed primary health facility provides good health outcomes and cost-effective treatment for patients.
Journal ArticleDOI
Mammography Surveillance and Mortality in Older Breast Cancer Survivors
Timothy L. Lash,Matthew P. Fox,Diana S.M. Buist,Feifei Wei,Terry S. Field,Floyd J. Frost,Ann M. Geiger,Virginia P. Quinn,Marianne Ulcickas Yood,Rebecca A. Silliman +9 more
TL;DR: This large observational study provides support for the recommendations, suggesting that receipt of surveillance mammograms reduces the rate of breast cancer mortality in older patients diagnosed with early-stage disease.
Journal ArticleDOI
Cough Aerosols of Mycobacterium tuberculosis Predict New Infection. A Household Contact Study
Edward C. Jones-López,Olive Namugga,Francis Mumbowa,Martin Ssebidandi,Olive Mbabazi,Stephanie Moine,Gerald Mboowa,Matthew P. Fox,Nancy Reilly,Irene Ayakaka,Soyeon Kim,Alphonse Okwera,Moses Joloba,Kevin P. Fennelly +13 more
TL;DR: Cough aerosols are produced by a minority of patients with tuberculosis but predict transmission better than sputum smear microscopy or culture, and may help identify the most infectious patients with TB and thus improve the cost-effectiveness of TB control programs.
Journal ArticleDOI
Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.
Olivia Keiser,Benjamin H. Chi,Thomas Gsponer,Andrew Boulle,Catherine Orrell,Sam Phiri,Nicola Maxwell,Mhairi Maskew,Hans Prozesky,Matthew P. Fox,Matthew P. Fox,Andrew O. Westfall,Matthias Egger +12 more
TL;DR: Over 3 years of ART mortality was lower in South Africa than in Malawi or Zambia, which might be explained by viral load monitoring leading to earlier detection of treatment failure, adherence counselling and timelier switching to second-line ART.
Journal ArticleDOI
Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa.
Bruce A. Larson,Alana T. Brennan,Lynne McNamara,Lawrence Long,Sydney Rosen,Ian Sanne,Matthew P. Fox +6 more
TL;DR: This study aims to estimate loss to follow up (LTFU) between initial enrolment and the first scheduled return medical visit of a pre‐antiretroviral therapy (ART) care program for patients not eligible for ART.